Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease (Q39167266)

From Wikidata

Jump to navigation Jump to search

scientific article published on 6 March 2012

Language	Label	Description	Also known as
English	Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease	scientific article published on 6 March 2012

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease (English)

1 reference

Europe PubMed Central

9 September 2017

Human T-lymphotropic virus 1

0 references

1 reference

based on heuristic

inferred from title

author name string

Sangmin Lee

1

1 reference

Europe PubMed Central

9 September 2017

Yoojin Shin

2

1 reference

Europe PubMed Central

9 September 2017

Daniel Clark

3

1 reference

Europe PubMed Central

9 September 2017

Eduardo Gotuzzo

4

1 reference

Europe PubMed Central

9 September 2017

Michael C Levin

5

1 reference

Europe PubMed Central

9 September 2017

publication date

6 March 2012

1 reference

Europe PubMed Central

9 September 2017

Journal of Clinical Immunology

1 reference

Europe PubMed Central

9 September 2017

32

1 reference

Europe PubMed Central

9 September 2017

736-745

1 reference

Europe PubMed Central

9 September 2017

4

1 reference

Europe PubMed Central

9 September 2017

https://scigraph.springernature.com/pub.10.1007/s10875-012-9652-9

0 references

Glycosylation and the immune system

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Glycosylation: An intrinsic sign of "danger"

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Mammalian glycosylation in immunity

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Mammalian N-glycan branching protects against innate immune self-recognition and inflammation in autoimmune disease pathogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Post-translational glycosylation of target proteins implicate molecular mimicry in the pathogenesis of HTLV-1 associated neurological disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Molecular mimicry in neurological disease: what is the evidence?

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Autoimmunity due to molecular mimicry as a cause of neurological disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Ganglioside mimicry and peripheral nerve disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Tubulin is a neuronal target of autoantibodies in Sydenham's chorea

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

A functional and structural basis for TCR cross-reactivity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

A suspenseful game of 'hide and seek' between virus and host

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Immunologic analysis of a spinal cord-biopsy specimen from a patient with human T-cell lymphotropic virus type I-associated neurologic disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

HTLV-I associated myelopathy, a new clinical entity.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

A potential link between autoimmunity and neurodegeneration in immune-mediated neurological disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Neuronal molecular mimicry in immune-mediated neurologic disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

HTLV-I/II seroindeterminate Western blot reactivity in a cohort of patients with neurological disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Intracellular distribution of human T-cell leukemia virus type 1 Gag proteins is independent of interaction with intracellular membranes.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

The HTLV-I envelope glycoproteins: structure and functions

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

The immune response to HTLV-I.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP).

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Siglecs and their roles in the immune system

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Differential immune responsiveness to the immunodominant epitopes of regulatory proteins (tax and rex) in human T cell lymphotropic virus type I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Posttranslationally modified peptides efficiently mimicking neoantigens: a challenge for theragnostics of autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9652-9

21 January 2018

Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22392044

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mimicry and immune-mediated diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22392044

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mimicry: anti-DNA antibodies bind microbial and nonnucleic acid self-antigens

1 reference

https://pubmed.ncbi.nlm.nih.gov/22392044

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/22392044

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/22392044

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Purification of the oligosaccharide-cleaving enzymes of Flavobacterium meningosepticum

1 reference

https://pubmed.ncbi.nlm.nih.gov/22392044

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10875-012-9652-9

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39167266&oldid=1811559940"